---
title: "Eyepoint Pharmaceuticals, Inc. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/e6b3feab-93f8-4a43-82de-e587c4816293
json: https://whiteintel.dev/api/public/dossier/e6b3feab-93f8-4a43-82de-e587c4816293
identifier: gb-coh:4515023
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Eyepoint Pharmaceuticals, Inc.

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:4515023`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/e6b3feab-93f8-4a43-82de-e587c4816293  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/e6b3feab-93f8-4a43-82de-e587c4816293  

## Ownership & control

### Holdings / subsidiaries

- **Eyepoint Pharmaceuticals, Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/9fa71129-9a86-5772-aedc-ff446b63fc15

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Eyepoint Pharmaceuticals, Inc.**. Human view: https://whiteintel.dev/entity/e6b3feab-93f8-4a43-82de-e587c4816293 · Structured JSON: https://whiteintel.dev/api/public/dossier/e6b3feab-93f8-4a43-82de-e587c4816293._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._